Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior.

Vardy E, Robinson JE, Li C, Olsen RHJ, DiBerto JF, Giguere PM, Sassano FM, Huang XP, Zhu H, Urban DJ, White KL, Rittiner JE, Crowley NA, Pleil KE, Mazzone CM, Mosier PD, Song J, Kash TL, Malanga CJ, Krashes MJ, Roth BL.

Neuron. 2015 May 20;86(4):936-946. doi: 10.1016/j.neuron.2015.03.065. Epub 2015 Apr 30.

2.

Unilateral abducens nerve palsy in a child with rapidly increasing head circumference.

Pudukadan C, Shankar P, White C, Gertsch KR, Elton SW, Malanga CJ.

Neurology. 2015 Apr 21;84(16):1719. doi: 10.1212/WNL.0000000000001503. No abstract available.

3.

Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism.

Robinson JE, Vardy E, DiBerto JF, Chefer VI, White KL, Fish EW, Chen M, Gigante E, Krouse MC, Sun H, Thorsell A, Roth BL, Heilig M, Malanga CJ.

Neuropsychopharmacology. 2015 Oct;40(11):2614-22. doi: 10.1038/npp.2015.109. Epub 2015 Apr 16.

4.

A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.

Bilbao A, Robinson JE, Heilig M, Malanga CJ, Spanagel R, Sommer WH, Thorsell A.

Biol Psychiatry. 2015 May 15;77(10):850-8. doi: 10.1016/j.biopsych.2014.08.021. Epub 2014 Sep 8.

PMID:
25442002
5.

The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo.

White KL, Robinson JE, Zhu H, DiBerto JF, Polepally PR, Zjawiony JK, Nichols DE, Malanga CJ, Roth BL.

J Pharmacol Exp Ther. 2015 Jan;352(1):98-109. doi: 10.1124/jpet.114.216820. Epub 2014 Oct 15.

6.

Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice.

Fish EW, DiBerto JF, Krouse MC, Robinson JE, Malanga CJ.

J Pharmacol Exp Ther. 2014 Aug;350(2):322-9. doi: 10.1124/jpet.114.216135. Epub 2014 Jun 10.

7.

Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice.

Fish EW, Whitman BJ, DiBerto JF, Robinson JE, Morrow AL, Malanga CJ.

Psychopharmacology (Berl). 2014 Sep;231(17):3415-3423. doi: 10.1007/s00213-014-3600-8. Epub 2014 May 9.

8.

Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Fish EW, Agoglia AE, Krouse MC, Muller RG, Robinson JE, Malanga CJ.

Behav Pharmacol. 2014 Feb;25(1):61-70. doi: 10.1097/FBP.0000000000000019.

9.

Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome.

Fish EW, Krouse MC, Stringfield SJ, Diberto JF, Robinson JE, Malanga CJ.

PLoS One. 2013 Oct 18;8(10):e77896. doi: 10.1371/journal.pone.0077896. eCollection 2013.

10.

Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice.

Robinson JE, Chen M, Stamatakis AM, Krouse MC, Howard EC, Faccidomo S, Hodge CW, Fish EW, Malanga CJ.

Neuropsychopharmacology. 2013 Jun;38(7):1322-33. doi: 10.1038/npp.2013.30. Epub 2013 Jan 25.

11.

Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.

Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM, Philpot BD, Malanga CJ.

J Clin Invest. 2012 Dec;122(12):4544-54. doi: 10.1172/JCI61888. Epub 2012 Nov 12.

12.

Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Robinson JE, Agoglia AE, Fish EW, Krouse MC, Malanga CJ.

Behav Brain Res. 2012 Sep 1;234(1):76-81. doi: 10.1016/j.bbr.2012.06.012. Epub 2012 Jun 21.

13.

The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice.

Riday TT, Kosofsky BE, Malanga CJ.

Neuropharmacology. 2012 Mar;62(4):1858-66. doi: 10.1016/j.neuropharm.2011.12.011. Epub 2011 Dec 16.

14.

Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ.

Brain Res. 2012 Jan 11;1431:53-61. doi: 10.1016/j.brainres.2011.11.003. Epub 2011 Nov 7.

15.

Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine.

Fish EW, Robinson JE, Krouse MC, Hodge CW, Reed C, Phillips TJ, Malanga CJ.

Psychopharmacology (Berl). 2012 Apr;220(4):719-30. doi: 10.1007/s00213-011-2523-x. Epub 2011 Oct 7.

16.

Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.

Robinson JE, Fish EW, Krouse MC, Thorsell A, Heilig M, Malanga CJ.

Psychopharmacology (Berl). 2012 Mar;220(1):215-24. doi: 10.1007/s00213-011-2469-z. Epub 2011 Sep 10.

17.

Definition and classification of hyperkinetic movements in childhood.

Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, Singer HS, Alter K, Ben-Pazi H, Butler EE, Chen R, Collins A, Dayanidhi S, Forssberg H, Fowler E, Gilbert DL, Gorman SL, Gormley ME Jr, Jinnah HA, Kornblau B, Krosschell KJ, Lehman RK, MacKinnon C, Malanga CJ, Mesterman R, Michaels MB, Pearson TS, Rose J, Russman BS, Sternad D, Swoboda KJ, Valero-Cuevas F.

Mov Disord. 2010 Aug 15;25(11):1538-49. doi: 10.1002/mds.23088. Review.

18.

Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.

Timmermann L, Pauls KA, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S.

Brain. 2010 Mar;133(Pt 3):701-12. doi: 10.1093/brain/awq022. Epub 2010 Mar 5.

19.

Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice.

Fish EW, Riday TT, McGuigan MM, Faccidomo S, Hodge CW, Malanga CJ.

Alcohol Clin Exp Res. 2010 Jan;34(1):81-9. doi: 10.1111/j.1530-0277.2009.01069.x. Epub 2009 Oct 23.

20.

Still no time for complacency: Developmental effects of prenatal methamphetamine exposure.

Malanga CJ.

Neurology. 2009 Jun 16;72(24):2062-3. doi: 10.1212/WNL.0b013e3181a92c98. Epub 2009 Apr 29. No abstract available.

PMID:
19403882
21.

Augmentation of cocaine-sensitized dopamine release in the nucleus accumbens of adult mice following prenatal cocaine exposure.

Malanga CJ, Ren JQ, Guerriero RM, Kosofsky BE.

Dev Neurosci. 2009;31(1-2):76-89. doi: 10.1159/000207496. Epub 2009 Apr 17.

PMID:
19372689
22.

Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice.

Malanga CJ, Pejchal M, Kosofsky BE.

Pharmacol Biochem Behav. 2007 Oct;87(4):462-71. Epub 2007 Jun 21.

23.

Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice.

Malanga CJ, Riday TT, Carlezon WA Jr, Kosofsky BE.

Biol Psychiatry. 2008 Jan 15;63(2):214-21. Epub 2007 Jun 13.

24.

Neuropathological consequences of prenatal cocaine exposure in the mouse.

Ren JQ, Malanga CJ, Tabit E, Kosofsky BE.

Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):309-20.

25.

Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure.

Malanga CJ, Kosofsky BE.

Brain Res Dev Brain Res. 2003 Dec 30;147(1-2):47-57. Review.

PMID:
14741750
26.

Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice.

Gilliss B, Malanga CJ, Pieper JO, Carlezon WA Jr.

Psychopharmacology (Berl). 2002 Sep;163(2):238-48. Epub 2002 Jul 13.

PMID:
12202971
27.

A cell-based drug delivery system for lung targeting: II. Therapeutic activities on B16-F10 melanoma in mouse lungs.

Shao J, DeHaven J, Lamm D, Weissman DN, Malanga CJ, Rojanasakul Y, Ma JK.

Drug Deliv. 2001 Apr-Jun;8(2):71-6.

PMID:
11400865
28.

A cell-based drug delivery system for lung targeting: I. Preparation and pharmacokinetics.

Shao J, DeHaven J, Lamm D, Weissman DN, Runyan K, Malanga CJ, Rojanasakul Y, Ma JK.

Drug Deliv. 2001 Apr-Jun;8(2):61-9.

PMID:
11400864
29.

Inhibition of endotoxin-induced lung inflammation by interleukin-10 gene transfer in mice.

Dokka S, Malanga CJ, Shi X, Chen F, Castranova V, Rojanasakul Y.

Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L872-7.

30.

Characterization of proteolytic activities of pulmonary alveolar epithelium.

Yang X, Ma JK, Malanga CJ, Rojanasakul Y.

Int J Pharm. 2000 Feb 15;195(1-2):93-101.

PMID:
10675687
31.

Mechanisms of action of drugs of abuse on the developing fetal brain.

Malanga CJ 3rd, Kosofsky BE.

Clin Perinatol. 1999 Mar;26(1):17-37, v-vi. Review.

PMID:
10214541
32.

Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents.

Kumra S, Jacobsen LK, Lenane M, Karp BI, Frazier JA, Smith AK, Bedwell J, Lee P, Malanga CJ, Hamburger S, Rapoport JL.

J Am Acad Child Adolesc Psychiatry. 1998 Apr;37(4):377-85.

PMID:
9549958
33.

Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia.

Kumra S, Jacobsen LK, Lenane M, Smith A, Lee P, Malanga CJ, Karp BI, Hamburger S, Rapoport JL.

J Am Acad Child Adolesc Psychiatry. 1998 Feb;37(2):221-7.

PMID:
9473920
34.

Piperacillin-induced seizures.

Malanga CJ, Kokontis L, Mauzy S.

Clin Pediatr (Phila). 1997 Aug;36(8):475-8. No abstract available.

PMID:
9272322
35.

Hyperpolarizing effects of morphine, clonidine and 2-chloroadenosine in myenteric neurons associated with tolerance to morphine.

Meng J, Malanga CJ, Kong JQ, Taylor DA, Fleming WW.

J Pharmacol Exp Ther. 1997 Apr;281(1):41-7.

PMID:
9103478
36.

Chronic morphine treatment of guinea pigs induces nonspecific sensitivity changes in the nucleus tractus solitarius in vitro.

Malanga CJ, Meng J, Fleming WW, Taylor DA.

J Pharmacol Exp Ther. 1997 Jan;280(1):16-23.

PMID:
8996176
37.

Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis.

Liang WW, Shi X, Deshpande D, Malanga CJ, Rojanasakul Y.

Biochim Biophys Acta. 1996 Mar 13;1279(2):227-34.

38.

Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis.

Rojanasakul Y, Wang LY, Malanga CJ, Ma JK, Liaw J.

Pharm Res. 1994 Dec;11(12):1731-6.

PMID:
7899236
39.

Receptor-mediated peptide delivery in pulmonary epithelial monolayers.

Deshpande D, Toledo-Velasquez D, Wang LY, Malanga CJ, Ma JK, Rojanasakul Y.

Pharm Res. 1994 Aug;11(8):1121-6.

PMID:
7971712
40.

Alveolar permeability enhancement by oleic acid and related fatty acids: evidence for a calcium-dependent mechanism.

Wang LY, Ma JK, Pan WF, Toledo-Velasquez D, Malanga CJ, Rojanasakul Y.

Pharm Res. 1994 Apr;11(4):513-7.

PMID:
8058607
41.

Regulation of tight junction permeability by calcium mediators and cell cytoskeleton in rabbit tracheal epithelium.

Bhat M, Toledo-Velasquez D, Wang L, Malanga CJ, Ma JK, Rojanasakul Y.

Pharm Res. 1993 Jul;10(7):991-7.

PMID:
8378262
42.

Altered calcium homeostasis and cell injury in silica-exposed alveolar macrophages.

Rojanasakul Y, Wang L, Malanga CJ, Ma JY, Banks DE, Ma JK.

J Cell Physiol. 1993 Feb;154(2):310-6.

PMID:
8381126
43.

The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit.

Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JK.

Pharm Res. 1992 Aug;9(8):1029-34.

PMID:
1409373
45.

Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: correlation between binding affinity, inhibitory potency, and antifibrotic potential.

Castranova V, Kang JH, Ma JK, Mo CG, Malanga CJ, Moore MD, Schwegler-Berry D, Ma JY.

Toxicol Appl Pharmacol. 1991 Apr;108(2):242-52.

PMID:
2017754
46.

Synthesis and secretion of mucous glycoprotein by the gill of Mytilus edulis. I. Histochemical and chromatographic analysis of [14C]glucosamine bioincorporation.

Ahn HY, Sue LF, Ma JK, Pinkstaff CA, Pore RS, Overman DO, Malanga CJ.

Biochim Biophys Acta. 1988 Jul 14;966(1):122-32.

PMID:
3390462
47.

A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading.

Leelarasamee N, Howard SA, Malanga CJ, Ma JK.

J Microencapsul. 1988 Apr-Jun;5(2):147-57.

PMID:
3199303
48.

Kinetics of drug release from polylactic acid-hydrocortisone microcapsules.

Leelarasamee N, Howard SA, Malanga CJ, Luzzi LA, Hogan TF, Kandzari SJ, Ma JK.

J Microencapsul. 1986 Jul-Sep;3(3):171-9.

PMID:
3508185
49.

Preparation and in vitro evaluation of polylactic acid-mitomycin C microcapsules.

Tsai DC, Howard SA, Hogan TF, Malanga CJ, Kandzari SJ, Ma JK.

J Microencapsul. 1986 Jul-Sep;3(3):181-93.

PMID:
3149671

Supplemental Content

Loading ...
Support Center